These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 26096139
21. Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summary. Kluetz PG, Ning YM, Maher VE, Zhang L, Tang S, Ghosh D, Aziz R, Palmby T, Pfuma E, Zirkelbach JF, Mehrotra N, Tilley A, Sridhara R, Ibrahim A, Justice R, Pazdur R. Clin Cancer Res; 2013 Dec 15; 19(24):6650-6. PubMed ID: 24150234 [Abstract] [Full Text] [Related]
22. Concomitant intake of abiraterone acetate and food to increase pharmacokinetic exposure: real life data from a therapeutic drug monitoring programme. Groenland SL, van Nuland M, Bergman AM, de Feijter JM, Dezentje VO, Rosing H, Beijnen JH, Huitema ADR, Steeghs N, Dutch Pharmacology Oncology Group (DPOG). Eur J Cancer; 2020 May 15; 130():32-38. PubMed ID: 32172196 [Abstract] [Full Text] [Related]
23. Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment. Marbury T, Lawitz E, Stonerock R, Gonzalez M, Jiao J, Breeding J, Haqq C, Verboven P, Stieltjes H, Yu M, Molina A, Acharya M, Chien C, Tran N. J Clin Pharmacol; 2014 Jul 15; 54(7):732-41. PubMed ID: 24374856 [Abstract] [Full Text] [Related]
24. Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects. Nirogi R, Ravula J, Benade V, Goyal VK, Pandey SK, Dogiparti D, Jayarajan P, Kalaikadhiban I, Jetta S, Palacharla VRC. Cancer Chemother Pharmacol; 2024 Mar 15; 93(3):253-264. PubMed ID: 38157042 [Abstract] [Full Text] [Related]
27. eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer. Shore ND, Tutrone RF, Mariados NF, Nordquist LT, Mehlhaff BA, Steere KJ, Harrelson SS. Clin Genitourin Cancer; 2018 Apr 15; 16(2):149-154. PubMed ID: 29196208 [Abstract] [Full Text] [Related]
28. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies. Williams DD, Peng B, Bailey CK, Wire MB, Deng Y, Park JW, Collins DA, Kapsi SG, Jenkins JM. Clin Ther; 2009 Apr 15; 31(4):764-76. PubMed ID: 19446149 [Abstract] [Full Text] [Related]
31. Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial. Basch E, Autio K, Ryan CJ, Mulders P, Shore N, Kheoh T, Fizazi K, Logothetis CJ, Rathkopf D, Smith MR, Mainwaring PN, Hao Y, Griffin T, Li S, Meyers ML, Molina A, Cleeland C. Lancet Oncol; 2013 Nov 15; 14(12):1193-9. PubMed ID: 24075621 [Abstract] [Full Text] [Related]
32. Effect of food and polymorphisms in SLCO2B1, CYP3A4 and UGT1A4 on pharmacokinetics of abiraterone and its metabolites in Chinese volunteers. Hu Y, Wu J, Cheng B, You R, Yin X, Chen G, Yang L, Zhang Y, Si L, Jiang H, Zhang Y, Huang J, Huang J. Br J Clin Pharmacol; 2024 Jan 15; 90(1):247-263. PubMed ID: 37574850 [Abstract] [Full Text] [Related]
33. Effects of food on the pharmacokinetics of ponatinib in healthy subjects. Narasimhan NI, Dorer DJ, Niland K, Haluska F, Sonnichsen D. J Clin Pharm Ther; 2013 Dec 15; 38(6):440-4. PubMed ID: 23888935 [Abstract] [Full Text] [Related]
34. Effect of dietary fat content in meals on pharmacokinetics of quazepam. Yasui-Furukori N, Kondo T, Takahata T, Mihara K, Ono S, Kaneko S, Tateishi T. J Clin Pharmacol; 2002 Dec 15; 42(12):1335-40. PubMed ID: 12463728 [Abstract] [Full Text] [Related]
35. Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome. Colomba E, Marret G, Baciarello G, Lavaud P, Massard C, Loriot Y, Albiges L, Carton E, Alexandre J, Huillard O, Culine S, Fizazi K. Eur J Cancer; 2020 Apr 15; 129():117-122. PubMed ID: 32151941 [Abstract] [Full Text] [Related]
36. A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer. Azad AA, Leibowitz-Amit R, Eigl BJ, Lester R, Wells JC, Murray RN, Kollmannsberger C, Heng DY, Joshua AM, Chi KN. Prostate; 2014 Nov 15; 74(15):1544-50. PubMed ID: 25175831 [Abstract] [Full Text] [Related]
37. Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect. Solymosi T, Ötvös Z, Angi R, Ordasi B, Jordán T, Molnár L, McDermott J, Zann V, Church A, Mair S, Filipcsei G, Heltovics G, Glavinas H. Cancer Chemother Pharmacol; 2017 Oct 15; 80(4):723-728. PubMed ID: 28776077 [Abstract] [Full Text] [Related]
38. Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors. Procopio G, Grassi P, Testa I, Verzoni E, Torri V, Salvioni R, Valdagni R, de Braud F. Am J Clin Oncol; 2015 Oct 15; 38(5):479-82. PubMed ID: 24064757 [Abstract] [Full Text] [Related]
39. Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies. Preskorn S, Ereshefsky L, Chiu YY, Poola N, Loebel A. Hum Psychopharmacol; 2013 Sep 15; 28(5):495-505. PubMed ID: 24014143 [Abstract] [Full Text] [Related]
40. Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects. Bouhajib M, Tayab Z. Clin Drug Investig; 2019 Mar 15; 39(3):309-317. PubMed ID: 30671920 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]